- Home
- HSIC vs LNTH Comparison
HSIC vs LNTH Comparison
Compare HSIC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSIC
- LNTH
- Stock Information
- Founded
- HSIC 1932
- LNTH 1956
- Country
- HSIC United States
- LNTH United States
- Employees
- HSIC N/A
- LNTH N/A
- Industry
- HSIC Medical Specialities
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HSIC Health Care
- LNTH Health Care
- Exchange
- HSIC Nasdaq
- LNTH Nasdaq
- Market Cap
- HSIC 8.1B
- LNTH 7.5B
- IPO Year
- HSIC 1995
- LNTH 2015
- Fundamental
- Price
- HSIC $72.08
- LNTH $75.13
- Analyst Decision
- HSIC Buy
- LNTH Strong Buy
- Analyst Count
- HSIC 10
- LNTH 5
- Target Price
- HSIC $79.30
- LNTH $133.80
- AVG Volume (30 Days)
- HSIC 1.5M
- LNTH 1.5M
- Earning Date
- HSIC 05-05-2025
- LNTH 05-07-2025
- Dividend Yield
- HSIC N/A
- LNTH N/A
- EPS Growth
- HSIC 8.11
- LNTH N/A
- EPS
- HSIC 3.21
- LNTH 3.53
- Revenue
- HSIC $12,669,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- HSIC $4.27
- LNTH $4.96
- Revenue Next Year
- HSIC $3.56
- LNTH $10.25
- P/E Ratio
- HSIC $22.45
- LNTH $21.28
- Revenue Growth
- HSIC 1.75
- LNTH 12.53
- 52 Week Low
- HSIC $60.56
- LNTH $75.00
- 52 Week High
- HSIC $82.49
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- HSIC 63.04
- LNTH 27.24
- Support Level
- HSIC $69.64
- LNTH $77.01
- Resistance Level
- HSIC $73.86
- LNTH $81.50
- Average True Range (ATR)
- HSIC 1.84
- LNTH 3.52
- MACD
- HSIC 0.65
- LNTH -1.61
- Stochastic Oscillator
- HSIC 84.19
- LNTH 0.35
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.